Kilitch Drugs (India) informs about disclosure

23 Apr 2022 Evaluate

Kilitch Drugs (India) has informed that the exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Bhavin Mukund Mehta.

The above information is a part of company’s filings submitted to BSE.

Kilitch Drugs(India) Share Price

320.40 1.20 (0.38%)
22-Jan-2026 12:17 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1622.30
Dr. Reddys Lab 1222.90
Cipla 1378.60
Zydus Lifesciences 883.75
Lupin 2174.50
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×